Innovus deal takes Aytu into consumer healthcare

17 September 2019 - Deborah Wilkes

Premium

Aytu BioScience is entering the consumer healthcare market by acquiring fellow US company Innovus Pharmaceuticals in a cash and shares deal worth up to USD24 million.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: